FDA PHARMA TODAY

💊FDA PHARMA TODAY

Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Clinical Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer

http://www.ono.co.jp/eng/news/pdf/sm_cn180125.pdf